Join Qubittron at the Medical Affairs eXcellence Forum (MAX) on March 25, 2026, at the Sheraton Toronto Airport.
This one-day forum brings together leaders from across the pharmaceutical and biotechnology industries to explore how medical affairs teams can translate scientific insight into measurable healthcare impact.
The 2026 program focuses on practical innovation in healthcare, with discussions on AI adoption, real-world evidence, patient identification, and the evolving role of Medical Science Liaisons. Through keynotes, expert panels, and leadership conversations, participants will gain insights into how medical strategy can drive meaningful outcomes for patients and healthcare systems.
At this event, you can expect to:
-
Explore how AI is transforming healthcare, with keynote insights from Muhammad Mamdani on what is truly working in practice.
-
Hear from industry leaders discussing how AI and data can deliver real medical value and improve decision-making.
-
Learn how organizations are scaling real-world evidence (RWE) to identify patients and generate actionable insights.
-
Engage in discussions on the future of Medical Science Liaisons (MSLs) and the evolving role of medical affairs teams.
The event will also feature a panel on bridging medical strategy into real impact in the field, moderated by Daanyaal Bandukwala, Founder & Managing Director at INK PharmaSolutions, a valued partner of Qubittron.
We look forward to connecting with medical affairs leaders who are shaping the future of healthcare innovation.